116 related articles for article (PubMed ID: 10188141)
21. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
[TBL] [Abstract][Full Text] [Related]
22. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
[TBL] [Abstract][Full Text] [Related]
23. Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
Myśliwiec H; Myśliwiec P; Baran A; Flisiak I
Adv Med Sci; 2016 Sep; 61(2):207-211. PubMed ID: 26895458
[TBL] [Abstract][Full Text] [Related]
24. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
Caca-Biljanovska NG; V'lckova-Laskoska MT
Croat Med J; 2002 Dec; 43(6):707-12. PubMed ID: 12476481
[TBL] [Abstract][Full Text] [Related]
25. Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years.
Zampetti A; Barone A; Antuzzi D; Amerio P; Tulli A; Feliciani C; Amerio P
J Dermatolog Treat; 2008; 19(3):134-40. PubMed ID: 18569269
[TBL] [Abstract][Full Text] [Related]
26. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
27. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
Kavanagh GM; Burton JL; Donnell VO
Br J Dermatol; 1996 Feb; 134(2):234-7. PubMed ID: 8746335
[TBL] [Abstract][Full Text] [Related]
28. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
29. [Study on the relationship between epidermal growth factor and fetal growth retardation].
Dong M; He J; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):135-7. PubMed ID: 11263179
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effect of aminophylline and low PEEP vs. high PEEP on EGF concentration in critically ill patients with ALI/ARDS.
Salari P; Mojtahedzadeh M; Najafi A; Sadraie S; Bahaadini K; Moharreri M; Hadavand N; Abdollahi M
J Clin Pharm Ther; 2005 Apr; 30(2):139-44. PubMed ID: 15811166
[TBL] [Abstract][Full Text] [Related]
31. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
32. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
33. [A clinical study on changes of EGF in serum before and after endoscopic surgery in patients with chronic sinusitis disease].
Wang P; Shen Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):49-50. PubMed ID: 21473132
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
Schulte-Herbrüggen O; Fölster-Holst R; von Elstermann M; Augustin M; Hellweg R
Int Arch Allergy Immunol; 2007; 144(3):211-6. PubMed ID: 17579279
[TBL] [Abstract][Full Text] [Related]
35. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
Bovenschen HJ; Vissers WH; Seyger MM; van de Kerkhof PC
Acta Derm Venereol; 2005; 85(2):113-7. PubMed ID: 15823902
[TBL] [Abstract][Full Text] [Related]
36. Activity of Tumor Necrosis Factor-alfa (TNF-alpha) and selected acute phase proteins in plasma of psoriatic patients receiving local treatment.
Chodorowska G; Juszkiewicz-Borowiec M; Czelej D; Wojnowska D; Kowal M
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():165-9. PubMed ID: 11977304
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris.
Vali A; Asilian A; Khalesi E; Khoddami L; Shahtalebi M; Mohammady M
J Dermatolog Treat; 2005; 16(4):234-7. PubMed ID: 16249145
[TBL] [Abstract][Full Text] [Related]
38. The effect of treatment on quality of life in psoriasis patients.
Prins M; Krabbe PF; Swinkels QO; de Boo T; van de Kerkhof PC; van der Valk PG
Acta Derm Venereol; 2005; 85(4):304-10. PubMed ID: 16191850
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
40. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
